Conference Chairs
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
[/col] [col class="span3"]
Bruce Bloom
[/col] [col class="span3"]
[/col] [col class="span3"]
Aris Persidis, Ph.D.
[/col] [/row]
Speaking Faculty
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Ron Alfa, MD, Ph.D.
- Vice President, Discovery and Product
- Recursion Pharmaceuticals
[/col] [col class="span3"]
-
Bobbie Ann Austin, Ph.D.
- Program Officer, Drug Development Partnership Programs, NCATS, Office of the Director
- National Institutes of Health
[/col][col class="span3"]
-
Paul Bogdan, Ph.D.
- Assistant Professor, Department of Electrical Engineering
- University of Southern California
[/col][col class="span3"]
-
Pieter Dylst
- Senior Manager Market Access and Value Added Medicines
- Medicines for Europe
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Rodolphe Hajj, Ph.D.
- Chief Pharmacology Officer
- PharNext SA
[/col] [col class="span3"]
-
Laura Kleiman, Ph.D.
- Executive Director
- Cures Within Reach for Cancer
[/col][col class="span3"]
-
Daphna Laifenfeld, Ph.D.
- Senior Director, Personalized and Predictive Medicine
- Teva Pharmaceutical Industries
[/col][col class="span3"]
-
Kevin Pan, Ph.D.
- Chief Executive Officer
- Asieris Pharmaceuticals
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Xavier Paoli
- CCO and VP of R&D Operations
- PharNext SA
[/col] [col class="span3"]
-
Michael Pollastri, Ph.D.
- Associate Professor & Chair
- Northeastern University, College of Science
[/col] [col class="span3"]
-
Lieven Lagae, MD, Ph.D.
- Professor, Paediatric Neurology
- Katholieke Universiteit Leuven
[/col][col class="span3"]
-
Vidula Sukhatme
- Founder & CEO
- Global Cures
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Berish Y. Rubin, Ph.D.
- Professor, Department of Biological Sciences
- Fordham University
[/col] [col class="span3"]
-
Robert Lavieri, Ph.D.
- Project Manager, Vanderbilt Institute for Clinical and Translational Research
- Vanderbilt University Medical University
[/col] [col class="span3"]
-
Michael Tranfaglia, MD
- Medical Director, Chief Scientific Officer
- FRAXA Research Foundation
[/col] [col class="span3"]
-
Gregory Stewart, Ph.D.
- Chief Scientific Officer
- Pairnomix
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Chad Nivens, Ph.D.
- Director, Translational Science, Innovative Medicines & Early Development Biotech Unit
- AstraZeneca Pharmaceutical LP
[/col] [col class="span3"]
-
Clare Thibodeaux, Ph.D.
- Director of Scientific Affairs
- Cures Within Reach
[/col] [col class="span3"]
-
Scott Weir, Pharm.D., Ph.D.
- Frank B. Tyler Cancer Research Professor in Therapeutic Discovery, Director, Institute for Advancing Medical Innovation, Associate Director – Translational Research
- University of Kansas, University of Kansas Cancer Center
[/col] [col class="span3"]
-
Hermann Mucke, Ph.D.
- Principal
- H.M. Pharma Consultancy
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Maria Shkrob Ph.D.
- Professional Services Consultant
- Elsevier
[/col] [col class="span3"]
-
Sharlene Velichko, Ph.D.
- Director of Research Biology
- DiscoverX
[/col] [col class="span3"]
-
Andrew Reaume, Ph.D., MBA
- President and CEO
- Melior Discovery
[/col] [col class="span3"]
-
Nandu Gattu, Ph.D.
- Vice President, Pharma Analytics
- Excelra
[/col] [/row]
[row id="ROW_ID" class="ROW_CLASS"] [col class="span3"]
-
Ya'ara Goldschmidt, M.Sc, Ph.D.
- Manager, Machine Learning and Data Mining Group
- IBM
[/col] [col class="span3"]
-
Gregory Koytiger, Ph.D.
- Associate Director, Translational Research
- Immuneering Corporation
[/col] [/row]